Wall Street Analysts Think Newmont (NEM) Is a Good Investment: Is It? — Positive

NEM   Zacks Investment Research — November 14, 2025

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

image for news Wall Street Analysts Think Newmont (NEM) Is a Good Investment: Is It?

Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy? — Positive

ADMA   Zacks Investment Research — November 14, 2025

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

image for news Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy?

Timken Declares Quarterly Dividend of 35 Cents Per Share — Neutral

TKR   PRNewsWire — November 14, 2025

NORTH CANTON, Ohio , Nov. 14, 2025 /PRNewswire/ -- The board of directors of The Timken Company (NYSE: TKR; www.timken.com), a global technology leader in engineered bearings and industrial motion, today declared a quarterly cash dividend of 35 cents per share. The dividend is payable on Dec. 5, 2025, to shareholders of record as of Nov. 25, 2025.

image for news Timken Declares Quarterly Dividend of 35 Cents Per Share

Pearl Diver Credit Company: Shares Are A 'Maybe,' Preferreds Are A 'Yes' — Neutral

PDCC  PDPA   Seeking Alpha — November 14, 2025

Pearl Diver Credit Company specializes in CLO equity, but I favor its Series A preferred shares (PDPA) for their superior capital stack position. PDPA offers an 8% cumulative dividend, trades near par, and boasts a strong asset coverage ratio of nearly 400%, enhancing safety. With a mandatory redemption in December 2029 and a yield to maturity around 7.7%, PDPA provides attractive risk-adjusted returns.

image for news Pearl Diver Credit Company: Shares Are A 'Maybe,' Preferreds Are A 'Yes'

LOS ANGELES, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Fluor Corporation, (“Fluor” or the "Company") (NYSE: FLR) investors of a class action on behalf of investors that bought securities between February 18, 2025 and July 31, 2025, inclusive (the “Class Period”). Fluor investors have until November 14, 2025 to file a lead plaintiff motion.

image for news Portnoy Law Firm Announces Class Action on Behalf of Fluor Corporation Investors

LOS ANGELES, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against James Hardie Industries plc (“James Hardie” or “the Company”) (NYSE: JHX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 20, 2025, and August 18, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before December 23, 2025.

image for news JHX Investors Have Opportunity to Lead James Hardie Industries plc Securities Fraud Lawsuit with the Schall Law Firm

Intuitive Surgical Stock Is Up 31% Since October Lows After Powerful Earnings Turnaround — Positive

ISRG   Investors Business Daily — November 14, 2025

As the overall market trend weakens, one area that remains intact is medical stocks — namely Intuitive Surgical.

image for news Intuitive Surgical Stock Is Up 31% Since October Lows After Powerful Earnings Turnaround

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Telix To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Telix between February 21, 2025 and August 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 14, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Telix Pharmaceuticals Limited ("Telix" or the …

image for news TLX DEADLINE: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 - TLX

Autolus Therapeutics: Trading At Cash Is Not Justified With This Pipeline — Neutral

AUTL   Seeking Alpha — November 14, 2025

Autolus Therapeutics: Trading At Cash Is Not Justified With This Pipeline

image for news Autolus Therapeutics: Trading At Cash Is Not Justified With This Pipeline

Wall Street Doubles Down On Nvidia Amid AI Stock Slump — Positive

NVDA   Investors Business Daily — November 14, 2025

Wall Street analysts are expressing confidence in Nvidia stock to regain its mojo ahead of the AI chip leader's earnings report next week.

image for news Wall Street Doubles Down On Nvidia Amid AI Stock Slump

Nexstar Media: Market Not Appreciating Its Durability (Upgrade) — Positive

NXST   Seeking Alpha — November 14, 2025

Nexstar Media: Market Not Appreciating Its Durability (Upgrade)

image for news Nexstar Media: Market Not Appreciating Its Durability (Upgrade)

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Inspire Medical between August 6, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 14, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical Systems, Inc. …

image for news INSP DEADLINE: Faruqi & Faruqi Reminds Inspire Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026 - INSP

Dillard's Q3 Earnings Beat Estimates, Comparable Store Sales Rise 3% — Positive

DDS   Zacks Investment Research — November 14, 2025

DDS delivers a Q3 beat as sales rise 2.9% and comps climb 3%, sending shares up about 10% on stronger retail momentum.

image for news Dillard's Q3 Earnings Beat Estimates, Comparable Store Sales Rise 3%

FONAR Stock Gains Post Y/Y Decline in Q1 Earnings and Profit — Negative

FONR   Zacks Investment Research — November 14, 2025

FONR reports top-line growth for first-quarter fiscal 2026 amid earnings decline and increased SG&A and operating expenses.

image for news FONAR Stock Gains Post Y/Y Decline in Q1 Earnings and Profit

Can Goldman's Expansion in Private Equity Credit Drive Growth? — Positive

GS   Zacks Investment Research — November 14, 2025

GS ramps up private equity and credit with acquisitions, global expansion and boosted alternatives fundraising goals.

image for news Can Goldman's Expansion in Private Equity Credit Drive Growth?

Adobe's Selloff May Be Hiding A Value Story — Positive

ADBE   Forbes — November 14, 2025

We believe Adobe (ADBE) is starting to screen like a value candidate. The stock now trades nearly 40% below its 12-month high and at a price-to-sales ratio meaningfully below its three-year average — a rare reset for a premium software name.

image for news Adobe's Selloff May Be Hiding A Value Story

Robinhood Stock Testing Key Trendline Amid Tech Rotation — Negative

HOOD   Schaeffers Research — November 14, 2025

Robinhood Markets Inc (NASDAQ:HOOD) stock is struggling amid an extended tech sector rotation , last seen down 0.1% to trade at $121.39.

image for news Robinhood Stock Testing Key Trendline Amid Tech Rotation

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In KBR To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in KBR between May 6, 2025 and June 19, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 14, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against KBR, Inc. ("KBR" or the "Company") …

image for news KBR DEADLINE: Faruqi & Faruqi Reminds KBR Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 18, 2025 - KBR

LOS ANGELES, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Baxter International Inc. (“Baxter” or “the Company”) (NYSE: BAX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before December 15, 2025.

image for news BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm

Walmart stock falls as CEO set to retire — Negative

WMT   Proactive Investors — November 14, 2025

Walmart Inc (NYSE:WMT, ETR:WMT) shares slipped 2.5% in early trading on Friday after the retail giant disclosed that its CEO Doug McMillon is retiring early in 2026 after leading the company for nearly 12 years. McMillon will be succeeded by John Furner, who is currently the CEO of Walmart US, on February 1, 2026.

image for news Walmart stock falls as CEO set to retire